ConductScience.org, home

Paper17539055

Therapies for Alzheimer's disease.

Melnikova I. Nat Rev Drug Discov, 2007. Cited by 178 papers, by iCite.

Cite this record

ConductScience Library. Therapies for Alzheimer's disease. Papers, record 17539055. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17539055

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Therapies for Alzheimer's disease.
PubMed
Journal
Nat Rev Drug Discov
PubMed
Year
2007
PubMed
Publication types
News
PubMed
Citations, by iCite
178
iCite
Relative citation ratio, by iCite
4.4
iCite
Revised in PubMed
2013-11-21
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Melnikova IIrena

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alzheimer DiseaseMajor topic
Alzheimer Vaccines
Amyloid Precursor Protein Secretases
Amyloid beta-Peptides
Cholinesterase Inhibitors
Clinical Trials as Topic
Excitatory Amino Acid Antagonists
GABA Agonists
Humans
Immunization
Memantine
Receptors, N-Methyl-D-Aspartate
Taurine

Source PubMed

Download CSV of topics

Cited by73

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 178 citations.

PMIDTitleJournalYearIn PapersSource
42389265Advances in the treatment of Alzheimer's disease.Front Pharmacol2026https://conductscience.org/library/papers/42389265PubMed
42166149Cell type transcriptomic modules reveal shared molecular mechanisms in Alzheimer's and Parkinson's disease.Gigascience2026https://conductscience.org/library/papers/42166149PubMed
39814937DeepDrug as an expert guided and AI driven drug repurposing methodology for selecting the lead combination of drugs for Alzheimer's disease.Sci Rep2025https://conductscience.org/library/papers/39814937PubMed
39456229Unveiling the Potential of Phytocannabinoids: Exploring Marijuana's Lesser-Known Constituents for Neurological Disorders.Biomolecules2024https://conductscience.org/library/papers/39456229PubMed
38027768Network pharmacology and in vivo studies reveal the neuroprotective effects of paeoniflorin on Alzheimer's disease.Heliyon2023https://conductscience.org/library/papers/38027768PubMed
36984830Natural Corynanthe-Type Cholinesterase Inhibitors from Malaysian Uncaria attenuata Korth.: Isolation, Characterization, In Vitro and In Silico Studies.Metabolites2023https://conductscience.org/library/papers/36984830PubMed
36903581Cell Membrane Biomimetic Nanoparticles with Potential in Treatment of Alzheimer's Disease.Molecules2023https://conductscience.org/library/papers/36903581PubMed
35701806Mechanistic insight of the potential of geraniol against Alzheimer's disease.Eur J Med Res2022https://conductscience.org/library/papers/35701806PubMed
35630613Virtual Screening and Hit Selection of Natural Compounds as Acetylcholinesterase Inhibitors.Molecules2022https://conductscience.org/library/papers/35630613PubMed
34975502Therapeutic Mechanism and Key Alkaloids of Uncaria rhynchophylla in Alzheimer's Disease From the Perspective of Pathophysiological Processes.Front Pharmacol2021https://conductscience.org/library/papers/34975502PubMed
34904048Neuroprotection by dipeptidyl-peptidase-4 inhibitors and glucagon-like peptide-1 analogs via the modulation of AKT-signaling pathway in Alzheimer's disease.World J Biol Chem2021https://conductscience.org/library/papers/34904048PubMed
34220245Cholinesterase inhibitory activity of tinosporide and 8-hydroxytinosporide isolated from Tinospora cordifolia: In vitro and in silico studies targeting management of Alzheimer's disease.Saudi J Biol Sci2021https://conductscience.org/library/papers/34220245PubMed
34203850Hydrophobic Tagging-Mediated Degradation of Transcription Coactivator SRC-1.Int J Mol Sci2021https://conductscience.org/library/papers/34203850PubMed
33934227Role of MicroRNAs, Aptamers in Neuroinflammation and Neurodegenerative Disorders.Cell Mol Neurobiol2022https://conductscience.org/library/papers/33934227PubMed
33807157The Main Alkaloids in Uncaria rhynchophylla and Their Anti-Alzheimer's Disease Mechanism Determined by a Network Pharmacology Approach.Int J Mol Sci2021https://conductscience.org/library/papers/33807157PubMed
33509748[Network pharmacology-based study of the therapeutic mechanism of resveratrol for Alzheimer's disease].Nan Fang Yi Ke Da Xue Xue Bao2021https://conductscience.org/library/papers/33509748PubMed
33504788Plasmonic nanoparticle amyloid corona for screening Aβ oligomeric aggregate-degrading drugs.Nat Commun2021https://conductscience.org/library/papers/33504788PubMed
32952669Engineered targeting tLyp-1 exosomes as gene therapy vectors for efficient delivery of siRNA into lung cancer cells.Asian J Pharm Sci2020https://conductscience.org/library/papers/32952669PubMed
32948022Drugs Modulating CD4+ T Cells Blood-Brain Barrier Interaction in Alzheimer's Disease.Pharmaceutics2020https://conductscience.org/library/papers/32948022PubMed
32244635Ajmalicine and Reserpine: Indole Alkaloids as Multi-Target Directed Ligands Towards Factors Implicated in Alzheimer's Disease.Molecules2020https://conductscience.org/library/papers/32244635PubMed

See all 73 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17539055

GET https://conductscience.org/api/papers/v1/17539055/cited_by?page=2